Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Nat Med ; 78(3): 568-575, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38564154

RESUMEN

Oxomollugin is a degraded product of mollugin and was found to be an active compound that inhibits LPS-induced NF-κB activation. In this study, we investigated the inhibitory activity of oxomollugin, focusing on TLR4 signaling pathway, resulting in NF-κB activation. Oxomollugin inhibited the LPS-induced association of essential factors for initial activation of TLR4 signaling, MyD88, IRAK4 and TRAF6. Furthermore, oxomollugin showed suppressive effects on LPS-induced modification of IRAK1, IRAK2 and TRAF6, LPS-induced association of TRAF6-TAK1/TAB2, and followed by IKKα/ß phosphorylation, which critical in signal transduction leading to LPS-induced NF-κB activation. The consistent results suggested that oxomollugin inhibits LPS-induced NF-κB activation via the suppression against signal transduction in TLR4 signaling pathway.The activities of oxomollugin reported in this study provides a deeper understanding on biological activity of mollugin derivatives as anti-inflammatory compounds.


Asunto(s)
Lipopolisacáridos , FN-kappa B , Transducción de Señal , Receptor Toll-Like 4 , Receptor Toll-Like 4/metabolismo , FN-kappa B/metabolismo , Lipopolisacáridos/farmacología , Transducción de Señal/efectos de los fármacos , Animales , Ratones , Humanos , Células RAW 264.7 , Fosforilación/efectos de los fármacos , Factor 88 de Diferenciación Mieloide/metabolismo , Lactonas , Resorcinoles , Zearalenona/administración & dosificación
2.
J Antibiot (Tokyo) ; 72(2): 71-78, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30410008

RESUMEN

Coptidis rhizome (CR) is a widely used herbal medicine that contains protoberberine-type alkaloids. CR extract exhibits various pharmacologic activities. A previous study reported the isolation of Rhodococcus sp. strain BD7100 as a berberine (BBR)-utilizing bacterium, and the BBR-degradation pathway has been investigated. When we incubated strain BD7100 cells with CR extract, the number of viable cells declined with the degradation of components in the CR extract, and the culture broth exhibited antibacterial activity against strain BD7100. These results suggest that CR extract cultured in the presence of strain BD7100 contains one or more antibacterial agents. In this study, we isolated coptirhoquinone A (1) from CR extract incubated with strain BD7100 in Luria-Bertani (LB) medium, and the structure was elucidated using NMR and MS analysis. We also report the total synthesis and antimicrobial activities of 1 against bacteria, fungi, and Pythium sp.


Asunto(s)
Antibacterianos/farmacología , Medicamentos Herbarios Chinos/farmacología , Rhodococcus/crecimiento & desarrollo , Rhodococcus/metabolismo , Antibacterianos/química , Antifúngicos/farmacología , Antiprotozoarios/farmacología , Berberina/metabolismo , Coptis chinensis , Medicamentos Herbarios Chinos/química , Hongos/efectos de los fármacos , Extractos Vegetales/química , Extractos Vegetales/farmacología , Pythium/efectos de los fármacos , Quinonas/química , Quinonas/aislamiento & purificación , Quinonas/farmacología , Rhodococcus/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA